This ICR is approved for 24 months under the following conditions in order to provide for a trial run of this database: (1) During the intial round of applications, AHRQ agrees to compile the questions that come in about this ICR from interested applicants and prepare FAQs for future rounds of applications. These FAQs will be included with the request for renewal. (2) AHRQ agrees to also collect data on how many applications it receives and how many applications are ultimately included in the healthcare innovations database. This data will also be included in the request for renewal. AHRQ will also compile a list of why the excluded applications were excluded and use this information in the request for renewal to refine the inclusion/exclusion criteria. At that time, AHRQ should also determine more concretely whether this database is intended to be a showcase for AHRQÂs funded projects or a database of innovative interventions. In order for this database to be both, AHRQ would have to demonstrate that truly innovative interventions that were not funded by AHRQ were excluded if and only if they were of a lower evidence rating and/or less innovative in terms of how AHRQ is defining the term Âinnovative. (3) AHRQ will also prepare some kind of plan for evaluating the utility of this project (e.g. through customer satisfication surveys). This will require AHRQ to somehow Âtrack who comes to this website so that they can be surveyed at a later time about their satisfaction with the database. (4) Since the main users of this database will be those working on the front-lines of quality improvement and looking for solutions to their problems, providing data on innovations that did not work seems to have limited utility. However, since there can be utility in knowing what innovations failed for researchers or those who are trying to come up with innovations, information about failed innovations can be part of the database as long as they are listed separately from those innovations that seem to have worked. AHRQ agrees to separate the effective/efficacious innovations from the failed innovations so that visitors to the database can easily find what they are looking for. (5) The inclusion and exclusion criteria will be provided as part of the instructions to applicants. (6) AHRQ agrees to include its priorities (as listed in the supporting statement) in the instructions to applicants so that applicants understand the criteria on which they are being judged. (7) AHRQ agrees to place the evidence rating in the first section where the innovation is summarized so that visitors to the database can easily determine which innovations have what level of evidence rating. (8) AHRQ agrees to limit the database section that includes innovations that worked to those that are at least Âsuggestive on the evidence rating scale (i.e. "unproven" innovations will not be included). (9) Consistent with AHRQ memo of 1/12/09, AHRQ will provide the definition for Âtruly innovative in its instructions and requests for applications so that applicants understand more clearly what type of innovations AHRQ is looking for(i.e. "For the purposes of the AHRQ Health Care Innovations Exchange, innovation refers to the creative implementation of new or altered products, services, processes, systems, organizational structures, or business models as a means of improving one or more domains of health care quality. In this context, the Health Care Innovations Exchange sees innovations as activities that are generally perceived as new in a particular setting or for a particular population relative to the usual care delivery processes. Applying that view to this work, the Health Care Innovations Exchange team will assess the novelty of quality improvement initiatives/efforts against usual care delivery (or care processes). The context and conditions of the novel approach to improving quality are important elements in making that assessment.In addition to brand new ideas, the Health Care Innovations Exchange will welcome activities adapted from other industries to health care, transferred from one health care setting or market segment to another, drawn from settings in other countries, or applied to a new or different patient population. Innovators must be able to communicate to the Health Care Innovations Exchange team how their innovations differ from what is regarded as standard practice in their organizations and among similar organizations. The Health Care Innovations Exchange team will couple their working knowledge of the industry (and the knowledge of experts) with the innovators perspective in making a final decision about novelty.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
03/31/2011
36 Months From Approved
566
0
0
401
0
0
0
0
0
The Innovations Exchange will provide a national-level information hub to foster the implementation and adaptation of innovative strategies that improve health care quality and minimize disparities in the care received by different populations. It is intended to address stakeholder interest in a "one-stop shop" that presents digested and reliable information about health care delivery innovations along with their accompanying implementation tools and networking opportunities to share implementation strategies and techniques. Its target audiences, broadly defined, will be current and potential change agents in the U.S. health care system, including clinicians (e.g., physicians, nurses, and other providers), health system administrators, health plan managers, health service purchasers, regulators, and policymakers from relevant Federal and state agencies.
US Code:
42 USC 299
Name of Law: Healthcare Research and Quality Act of 1999
This request for OMB clearance is for a new information collection.
$38,873
No
No
Uncollected
Uncollected
Uncollected
Uncollected
Doris Lefkowitz 3014271477
Reginfo record details
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Form Form #4 Annual follow-up interview
List_Inclusion_Exclusion_Criteria_Final.doc
Attachment F -- 60 Day FRN -- AHRQ Healthcare Innovations Exchange Interview & Submission Guidlines.pdf
Annual follow-up interview